Individual Variability in Barriers Affecting People's Decision to Take HAART: A Qualitative Study Identifying Barriers to Being on HAART
- 1 December 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 20 (12) , 848-857
- https://doi.org/10.1089/apc.2006.20.848
Abstract
The efficacy of highly active antiretroviral therapy (HAART) has been well documented, particularly among HIV-infected individuals with CD4 cell counts below 200/mm3. Despite this, eligible individuals may continue to show some reluctance to use HAART. The present study explored the factors influencing patients' decision not to take HAART even though it was medically indicated according to current treatment guidelines and available at no cost to the individual. Fifteen eligible patients at an urban HIV clinic were interviewed regarding the barriers that affected their decision to decline HAART. Most participants had previous experience with antiretroviral therapy and though most believed that HAART was beneficial and felt confident that they could adhere to treatment, they did not feel HAART was the right choice for them at the present time. The Critical Incident Technique was used to identify and classify incidents participants identified as influencing their decision not to take HAART. A total of four categories emerged from the data: Medication Factors, Mood, Lack of Support, and Outcome Expectancies. The results of this study highlight the ambivalence individuals may feel when faced with the prospect of taking HAART. The extent to which each of these factors influenced their decision differed substantially among participants. Suggestions for possible clinical interventions that can be used to address these concerns are offered.Keywords
This publication has 17 references indexed in Scilit:
- Treatment for Adult HIV InfectionJAMA, 2004
- Antiretroviral Treatment for Adult HIV Infection in 2002JAMA, 2002
- "I will start treatment when I think the time is right": HIV-positive gay men talk about their decision not to access antiretroviral therapyAIDS Care, 2001
- Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug TherapyJAMA, 2001
- An Investigation of Why Eligible Patients Do Not Receive HAARTAIDS Patient Care and STDs, 2001
- AIDS across Europe, 1994–98: the EuroSIDA studyThe Lancet, 2000
- The reasoning behind decisions not to take up antiretroviral therapy in Australians infected with HIVInternational Journal of STD & AIDS, 2000
- Barriers to Use of Free Antiretroviral Therapy in Injection Drug UsersJAMA, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral TherapyJAMA, 1998